Tumour types
58 tumour types with at least one EU-approved targeted, immune or hormone therapy. Each page lists the approved indications, the biomarkers that decide them and what to test. The number is the count of approved indications.
Thoracic
Breast
Gynaecological
Genitourinary
Gastrointestinal
Head and neck
Skin
Eye
CNS
Endocrine
Musculoskeletal
Haematological
- Multiple myeloma39
- Chronic lymphocytic leukaemia23
- Chronic myeloid leukaemia19
- Follicular lymphoma19
- Acute lymphoblastic leukaemia18
- Acute myeloid leukaemia15
- Large B-cell lymphoma15
- Mantle cell lymphoma10
- Hodgkin lymphoma8
- Myeloproliferative neoplasms7
- T-cell lymphoma6
- Waldenström macroglobulinaemia5
- Systemic mastocytosis3
- Myelodysplastic syndromes2
- Myeloid/lymphoid neoplasms with eosinophilia and TK fusions2
- AL amyloidosis1
- Post-transplant lymphoproliferative disorder1
- Marginal zone lymphoma1
- Other B-cell lymphoma1
- Myelodysplastic/myeloproliferative neoplasms1
- Blastic plasmacytoid dendritic cell neoplasm1